Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Mitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Eur J Hum Genet. 2022 Mar;30(3):271-281. doi: 10.1038/s41431-021-00960-4. Epub 2021 Sep 15.
Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome, an intellectual disability syndrome first described in 2016, is caused by heterozygous loss-of-function variants in SON. Its encoded protein promotes pre-mRNA splicing of many genes essential for development. Whereas individual phenotypic traits have previously been linked to erroneous splicing of SON target genes, the phenotypic spectrum and the pathogenicity of missense variants have not been further evaluated. We present the phenotypic abnormalities in 52 individuals, including 17 individuals who have not been reported before. In total, loss-of-function variants were detected in 49 individuals (de novo in 47, inheritance unknown in 2), and in 3, a missense variant was observed (2 de novo, 1 inheritance unknown). Phenotypic abnormalities, systematically collected and analyzed in Human Phenotype Ontology, were found in all organ systems. Significant inter-individual phenotypic variability was observed, even in individuals with the same recurrent variant (n = 13). SON haploinsufficiency was previously shown to lead to downregulation of downstream genes, contributing to specific phenotypic features. Similar functional analysis for one missense variant, however, suggests a different mechanism than for heterozygous loss-of-function. Although small in numbers and while pathogenicity of these variants is not certain, these data allow for speculation whether de novo missense variants cause ZTTK syndrome via another mechanism, or a separate overlapping syndrome. In conclusion, heterozygous loss-of-function variants in SON define a recognizable syndrome, ZTTK, associated with a broad, severe phenotypic spectrum, characterized by a large inter-individual variability. These observations provide essential information for affected individuals, parents, and healthcare professionals to ensure appropriate clinical management.
朱-托基塔-武井-金(ZTTK)综合征是一种智力障碍综合征,于 2016 年首次描述,由 SON 的杂合功能丧失变异引起。其编码的蛋白促进许多对发育至关重要的基因的前体 mRNA 剪接。虽然先前已经将个别表型特征与 SON 靶基因的错误剪接联系起来,但错义变异的表型谱和致病性尚未进一步评估。我们介绍了 52 名个体的表型异常,包括以前未报道过的 17 名个体。总共在 49 名个体中检测到功能丧失变异(47 名个体为新生突变,2 名个体遗传情况未知),在 3 名个体中观察到错义变异(2 名新生突变,1 名遗传情况未知)。在人类表型本体论中系统收集和分析的表型异常,在所有器官系统中均有发现。即使在具有相同重复变异的个体中(n=13),也观察到显著的个体间表型变异性。先前已经表明,SON 单倍不足导致下游基因下调,导致特定的表型特征。然而,对一个错义变异的类似功能分析表明,其机制与杂合功能丧失不同。尽管数量较少,并且这些变异的致病性尚不确定,但这些数据允许推测新生错义变异是否通过另一种机制或单独的重叠综合征导致 ZTTK 综合征。总之,SON 中的杂合功能丧失变异定义了一种可识别的综合征,即 ZTTK,与广泛的、严重的表型谱相关,其特征是个体间存在较大的变异性。这些观察结果为受影响的个体、父母和医疗保健专业人员提供了必要的信息,以确保进行适当的临床管理。